Harvest Management’s Amedisys AMED Stock Holding History

Harvest Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-80,600	Closed	-$7.93M	–	67
2025 Q2	$7.93M	Buy	+80,600	New	+$7.63M	3.37%	8
2025 Q1	–	Sell	-17,000	Closed	-$1.54M	–	59
2024 Q4	$1.54M	Sell	17,000 -10,100	-37%	-$928K	0.75%	24
2024 Q3	$2.62M	Buy	+27,100	New	+$2.64M	1.33%	20
2022 Q4	–	Sell	-5,000	Closed	-$484K	–	45
2022 Q3	$484K	Buy	+5,000	New	+$596K	0.39%	45

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Harvest Management's AMED Position: Q3 2025 in Review

Harvest Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 72,762 shares — an estimated $7.16M sold.

Harvest Management first reported a position in AMED in Q3 2024 and held it in 4 quarters. The position peaked at $7.16M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Harvest Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Harvest Management sold 72,762 Amedisys shares in Q3 2025, an estimated $7.16M.
Harvest Management first reported a position in Amedisys in Q3 2024 and held it in 4 quarters.
Harvest Management's Amedisys position peaked at $7.16M in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Harvest Management's 13F filing for Q3 2025, filed 14 Nov 2025.